Suppr超能文献

用于测量晚期癌症患者谵妄严重程度的沟通能力量表和激越痛苦量表:一项效度研究

Communication Capacity Scale and Agitation Distress Scale to measure the severity of delirium in terminally ill cancer patients: a validation study.

作者信息

Morita T, Tsunoda J, Inoue S, Chihara S, Oka K

机构信息

Seirei Hospice, Seirei Mikatabara Hospital, 3453 Mikatabara-cho, Hamamatsu, Shizuoka 433-8558, Japan.

出版信息

Palliat Med. 2001 May;15(3):197-206. doi: 10.1191/026921601678576185.

Abstract

Although valid measurement of the severity of terminal delirium is of great importance in palliative care settings, existing instruments have considerable limitations. In order to quantify patients' communication capacity and agitated behaviour, two new operational observer-rating scales, the Communication Capacity Scale (Communication Scale) and Agitation Distress Scale (Agitation Scale), were validated. Thirty terminally ill cancer patients diagnosed with delirium were evaluated simultaneously by two palliative care physicians blinded to each other's coding using the Communication Scale and Agitation Scale. In addition, the Memorial Delirium Assessment Scale (MDAS), Delirium Rating Scale (DRS) and Sedation Scale were rated by one researcher. Both scales achieved high internal consistency and inter-rater reliability with Cronbach's alpha coefficients of 0.91 and 0.96, and Cohen's kappa values on each item of 0.72-1.00. The principal components analysis resulted in the emergence of only one component for each scale. The total score on the Communication Scale was highly associated with that of the MDAS (rho = 0.78), Sedation Scale (rho = 0.86), and cognitive items from the MDAS and DRS (rho = 0.83). The whole score on the Agitation Scale was significantly correlated with that of the DRS (rho = 0.61) and agitation items from the MDAS and DRS (rho = 0.61). In conclusion, the Communication Scale and Agitation Scale have acceptable reliability and validity to quantify patients' communication capacity and agitation symptoms of terminally ill cancer patients with delirium.

摘要

尽管在姑息治疗环境中对终末期谵妄的严重程度进行有效测量非常重要,但现有工具存在相当大的局限性。为了量化患者的沟通能力和激越行为,两种新的操作性观察者评定量表,即沟通能力量表(沟通量表)和激越痛苦量表(激越量表),进行了效度验证。30例被诊断为谵妄的晚期癌症患者由两名相互不知情编码情况的姑息治疗医生同时使用沟通量表和激越量表进行评估。此外,由一名研究人员对纪念谵妄评估量表(MDAS)、谵妄评定量表(DRS)和镇静量表进行评分。两个量表均具有较高的内部一致性和评分者间信度,Cronbach's α系数分别为0.91和0.96,各项目的Cohen's kappa值为0.72 - 1.00。主成分分析结果显示每个量表仅出现一个成分。沟通量表的总分与MDAS总分(rho = 0.78)、镇静量表总分(rho = 0.86)以及MDAS和DRS的认知项目总分(rho = 0.83)高度相关。激越量表的总分与DRS总分(rho = 0.61)以及MDAS和DRS的激越项目总分(rho = 0.61)显著相关。总之,沟通量表和激越量表在量化晚期癌症谵妄患者的沟通能力和激越症状方面具有可接受的信度和效度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验